Redsenol Takes a Big Step Forward Toward the Best Ginsenoside Brand

November 13 02:45 2018

Vancouver, British Columbia, Canada – Redsenol, a ginsenoside brand owned by Canada Royal Enoch Phytomedicine Ltd., has achieved a huge milestone with its medicinal ingredients ginsenosides getting highly reputed BSCG certification. Redsenol has two products, Redsenol Rare Ginsenosides Capsules and Redsenol-DAG Sublingual Pills.

The BSCG certification affirms that the ginsenosides of Canada Royal Enoch Phytomedicine, a result of 16 years of rare ginsenoside research, are free from contamination and harmful substances, and thus completely safe for consumption.

Canada Royal Enoch Phytomedicine Ltd. is a high-tech biopharmaceutical company dedicated to the herbal medicine research, and the company now is focusing on researching and developing safe, health-promoting and metabolized ginsenosides. Ginsenosides are the active ingredients of ginseng, proved with many medicinal benefits including antioxidation, anti-inflammation, and antineoplastic.

Credited with a set of strict scrutiny and certification system, BSCG certification is known as the gold standard in dietary supplements certification. Receiving BSCG certification takes Redsenol a big step forward toward the best ginsenoside brand.

In addition to the newly-certified safety and quality guarantee, Redsenol is also credited with its own unique biotechnological advantages. Ginsenosides cannot be directly absorbed in the human body without going through metabolism, which is a technological challenge for many companies. The proprietary technology developed by Canada Royal Enoch Phytomedicine transforms large quantities of prototype ginsenosides into metabolized and rare ginsenosides which are fully bio-available to the body in 15-20 minutes with complete potency.

Redsenol is intended to enhance physical capacity/performance, improve cognitive function, reduce mental fatigue, increase energy and resistance to stress, and promote cardiovascular health. Redsenol Capsules contains sixteen rare ginsenosides, namely Rk2, Rg3(S,R), Rh2(S,R), Rg5, Rk1, Rk3, Rh1(S,R), Rh3, Rh4, aPPT(S,R) and aPPD(S,R), and Redsenol-DAG with eight highly bioactive rare ginsenosides in a high concentration. With multiple highly active rare ginsenosides synergistically working together, Redsenol outperforms the products with only one or two rare ginsenosides.

Receiving BSCG certification would help improve the brand image among customers for Redsenol. It can give its consumers great confidence in the quality and safety of the products, especially considering that consumers are concerned about whether health products have false claims on the label or include contaminants or toxic chemicals.

About Canada Royal Enoch Phytomedicine Ltd.

Headquartered in Vancouver, Canada, Canada Royal Enoch Phytomedicine Ltd. is a hi-tech enterprise group mainly engaged in research, production and sales of natural plant-based products. We aim to extract active ingredients from natural herbal plants.

For more information, please visit: https://enophyto.com.

Media Contact
Company Name: Canada Royal Enoch Phytomedicine Ltd.
Contact Person: Susan Thomas
Email: Send Email
Phone: +1 (604) 638 9936
Country: Canada
Website: https://enophyto.com

  Categories: